- Home
- NRIM vs RVNC Comparison
NRIM vs RVNC Comparison
Compare NRIM & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIM
- RVNC
- Stock Information
- Founded
- NRIM 1990
- RVNC 1999
- Country
- NRIM United States
- RVNC United States
- Employees
- NRIM N/A
- RVNC N/A
- Industry
- NRIM Savings Institutions
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- NRIM Finance
- RVNC Health Care
- Exchange
- NRIM Nasdaq
- RVNC Nasdaq
- Market Cap
- NRIM 369.8M
- RVNC 546.4M
- IPO Year
- NRIM N/A
- RVNC 2014
- Fundamental
- Price
- NRIM $69.40
- RVNC $5.29
- Analyst Decision
- NRIM
- RVNC Buy
- Analyst Count
- NRIM 0
- RVNC 10
- Target Price
- NRIM N/A
- RVNC $10.86
- AVG Volume (30 Days)
- NRIM 23.6K
- RVNC 1.3M
- Earning Date
- NRIM 10-28-2024
- RVNC 11-06-2024
- Dividend Yield
- NRIM 3.63%
- RVNC N/A
- EPS Growth
- NRIM 13.73
- RVNC N/A
- EPS
- NRIM 5.78
- RVNC N/A
- Revenue
- NRIM $136,386,000.00
- RVNC $251,178,000.00
- Revenue This Year
- NRIM N/A
- RVNC $20.36
- Revenue Next Year
- NRIM $3.03
- RVNC $31.66
- P/E Ratio
- NRIM $11.78
- RVNC N/A
- Revenue Growth
- NRIM 6.71
- RVNC 40.23
- 52 Week Low
- NRIM $38.65
- RVNC $2.30
- 52 Week High
- NRIM $74.34
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- NRIM 50.80
- RVNC 44.50
- Support Level
- NRIM $68.06
- RVNC $5.10
- Resistance Level
- NRIM $73.14
- RVNC $5.43
- Average True Range (ATR)
- NRIM 1.54
- RVNC 0.17
- MACD
- NRIM -0.04
- RVNC 0.02
- Stochastic Oscillator
- NRIM 45.00
- RVNC 66.67
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.